Franklin Street Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $206K | Sell |
734
-40
| -5% | -$10.5K | 0.01% | 168 |
|
|
2026
Q1 | $207K | Buy |
+774
| New | +$210K | 0.01% | 164 |
|
|
2025
Q4 | – | Sell |
-777
| Closed | -$223K | – | 173 |
|
|
2025
Q3 | $223K | Hold |
777
| – | – | 0.01% | 158 |
|
|
2025
Q2 | $204K | Buy |
+777
| New | +$189K | 0.01% | 166 |
|
|
2025
Q1 | – | Sell |
-984
| Closed | -$226K | – | 164 |
|
|
2024
Q4 | $226K | Buy |
984
+1
| +0.1% | +$229 | 0.02% | 151 |
|
|
2024
Q3 | $220K | Sell |
983
-10
| -1% | -$2.2K | 0.01% | 155 |
|
|
2024
Q2 | $202K | Sell |
993
-736
| -43% | -$150K | 0.01% | 161 |
|
|
2024
Q1 | $378K | Sell |
1,729
-283
| -14% | -$62.3K | 0.03% | 114 |
|
|
2023
Q4 | $457K | Sell |
2,012
-212
| -10% | -$44.5K | 0.04% | 105 |
|
|
2023
Q3 | $447K | Sell |
2,224
-755
| -25% | -$159K | 0.04% | 103 |
|
|
2023
Q2 | $617K | Sell |
2,979
-1,606
| -35% | -$312K | 0.05% | 90 |
|
|
2023
Q1 | $904K | Sell |
4,585
-25,211
| -85% | -$5.19M | 0.08% | 76 |
|
|
2022
Q4 | $6.03M | Sell |
29,796
-13,365
| -31% | -$2.61M | 0.57% | 53 |
|
|
2022
Q3 | $7.59M | Sell |
43,161
-8,324
| -16% | -$1.7M | 0.77% | 49 |
|
|
2022
Q2 | $10.4M | Sell |
51,485
-28,919
| -36% | -$6.16M | 0.98% | 41 |
|
|
2022
Q1 | $18.2M | Sell |
80,404
-2,877
| -3% | -$677K | 1.47% | 25 |
|
|
2021
Q4 | $22.5M | Buy |
83,281
+21,627
| +35% | +$5.35M | 1.7% | 19 |
|
|
2021
Q3 | $14.9M | Sell |
61,654
-803
| -1% | -$202K | 1.27% | 27 |
|
|
2021
Q2 | $14.8M | Sell |
62,457
-781
| -1% | -$178K | 1.25% | 30 |
|
|
2021
Q1 | $13.9M | Buy |
63,238
+339
| +0.5% | +$68K | 1.29% | 29 |
|
|
2020
Q4 | $11M | Buy |
62,899
+768
| +1% | +$133K | 1.07% | 35 |
|
|
2020
Q3 | $10M | Sell |
62,131
-10,778
| -15% | -$1.71M | 1.08% | 33 |
|
|
2020
Q2 | $10.4M | Sell |
72,909
-3,860
| -5% | -$534K | 1.24% | 31 |
|
|
2020
Q1 | $8.34M | Sell |
76,769
-14,130
| -16% | -$2.04M | 1.21% | 32 |
|
|
2019
Q4 | $13.2M | Buy |
90,899
+759
| +0.8% | +$110K | 1.56% | 22 |
|
|
2019
Q3 | $13M | Sell |
90,140
-3,990
| -4% | -$582K | 1.64% | 19 |
|
|
2019
Q2 | $14M | Sell |
94,130
-45
| -0% | -$6.28K | 1.8% | 18 |
|
|
2019
Q1 | $12.4M | Buy |
94,175
+2,710
| +3% | +$334K | 1.72% | 16 |
|
|
2018
Q4 | $9.93M | Sell |
91,465
-1,032
| -1% | -$138K | 1.57% | 21 |
|
|
2018
Q3 | $13.8M | Buy |
92,497
+20,670
| +29% | +$3.14M | 1.87% | 13 |
|
|
2018
Q2 | $11.1M | Sell |
71,827
-70
| -0.1% | -$10.6K | 1.62% | 18 |
|
|
2018
Q1 | $9.99M | Buy |
71,897
+1,228
| +2% | +$180K | 1.5% | 19 |
|
|
2017
Q4 | $9.68M | Buy |
70,669
+12,432
| +21% | +$1.64M | 1.45% | 22 |
|
|
2017
Q3 | $7.55M | Sell |
58,237
-4,447
| -7% | -$593K | 1.24% | 29 |
|
|
2017
Q2 | $8.3M | Buy |
62,684
+1,822
| +3% | +$223K | 1.42% | 23 |
|
|
2017
Q1 | $7.5M | Sell |
60,862
-343
| -0.6% | -$40.6K | 1.32% | 27 |
|
|
2016
Q4 | $6.75M | Buy |
61,205
+18,788
| +44% | +$2.09M | 1.19% | 28 |
|
|
2016
Q3 | $5.01M | Sell |
42,417
-780
| -2% | -$91.9K | 0.91% | 46 |
|
|
2016
Q2 | $4.83M | Buy |
43,197
+483
| +1% | +$52K | 0.92% | 38 |
|
|
2016
Q1 | $4.3M | Buy |
42,714
+11,536
| +37% | +$1.11M | 0.85% | 37 |
|
|
2015
Q4 | $3.31M | Sell |
31,178
-279
| -0.9% | -$28.8K | 0.65% | 47 |
|
|
2015
Q3 | $2.93M | Buy |
31,457
+1,478
| +5% | +$153K | 0.58% | 52 |
|
|
2015
Q2 | $3.12M | Sell |
29,979
-99
| -0.3% | -$10.3K | 0.56% | 55 |
|
|
2015
Q1 | $3.26M | Buy |
30,078
+70
| +0.2% | +$7.2K | 0.6% | 56 |
|
|
2014
Q4 | $2.78M | Buy |
+30,008
| New | +$2.65M | 0.53% | 60 |
|
Other funds holding LH
Franklin Street Advisors's LH Position: Q2 2026 in Review
Franklin Street Advisors reduced its Labcorp (LH) stake by 5.2% in Q2 2026, selling an estimated $10.5K and leaving 734 shares worth $206K. The position accounts for 0.01% of the portfolio, ranked #168.
Franklin Street Advisors first reported a position in LH in Q4 2014 and has held it in 45 quarters since. The position peaked at $22.5M in Q4 2021. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Franklin Street Advisors held 734 shares of Labcorp worth $206K as of Q2 2026.
- Franklin Street Advisors sold 40 Labcorp shares in Q2 2026, an estimated $10.5K.
- Labcorp made up 0.01% of Franklin Street Advisors's portfolio in Q2 2026, its #168 holding.
- Franklin Street Advisors first reported a position in Labcorp in Q4 2014 and has held it in 45 quarters since.
- Franklin Street Advisors's Labcorp position peaked at $22.5M in Q4 2021.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.